Daniel Levangie is the founder of CereVasc. CereVasc has raised $85M in total funding. Latest round: Series C. Based in Charlestown, Massachusetts.
Daniel Levangie is the Chairman and Chief Executive Officer of CereVasc, Inc., a clinical-stage medical device company focused on developing novel, minimally invasive treatments for neurological diseases. The company recently closed an $85 million Series C financing round, led by Piper Sandler Merchant Banking, to advance its eShunt System for Normal Pressure Hydrocephalus. This funding will support the STRIDE pivotal trial, regulatory work, and preparations for US commercialization.
Full founder directory · Investor directory · Company funding database · Fundraising library